number
public
incid
biopharmaceut
product
experienc
contamin
viru
bacteri
agent
contamin
event
highli
disrupt
requir
product
halt
inventori
quarantin
extens
test
conduct
identifi
natur
sourc
contamin
cost
contamin
event
signific
exampl
cost
associ
vesiviru
contamin
event
genzym
estim
million
includ
fine
million
us
fda
addit
direct
indirect
cost
patient
whose
medic
becom
unavail
ultraviolet
uv
disinfect
appli
drink
water
centuri
first
instal
marseil
first
us
instal
henderson
ky
mani
million
peopl
reli
drink
water
disinfect
ultraviolet
light
includ
resid
new
york
citi
usa
vancouv
canada
benefit
uv
disinfect
includ
avoid
chemic
addit
well
simpl
control
mainten
uniqu
mode
action
uv
directli
affect
nucleic
acid
organ
viru
also
make
desir
orthogon
methodolog
complement
technolog
filtrat
chemic
inactiv
result
often
consid
treatment
method
small
organ
virus
readili
filter
suscept
chemic
disrupt
biopharmaceut
manufactur
genzym
sanofi
pasteur
consid
uv
promis
prospect
adventiti
agent
clearanc
technolog
mitig
risk
contamin
raw
materi
howev
reluct
implement
process
abstract
incid
contamin
biopharmaceut
product
highlight
need
appli
altern
supplementari
disinfect
techniqu
ultraviolet
uv
irradi
wellestablish
method
inactiv
broad
rang
microorgan
therefor
good
candid
orthogon
techniqu
disinfect
appli
uv
safeguard
adventiti
agent
uv
sensit
target
agent
must
known
appropri
dose
uv
may
appli
achiev
desir
level
inactiv
document
compil
review
experiment
deriv
nm
sensit
organ
relev
biopharmaceut
product
gener
differ
research
found
similar
sensit
valu
despit
lack
uniform
experiment
design
standard
quantif
techniqu
still
lack
consist
methodolog
led
suspici
uv
suscept
certain
instanc
justifi
need
creat
robust
collect
sensit
valu
use
design
size
uv
system
inactiv
adventiti
agent
keyword
biopharmaceut
adventiti
agent
ultraviolet
irradi
disinfect
viral
clearanc
lack
avail
literatur
topic
recent
effort
correct
undertaken
group
publish
research
consid
effect
uv
fluenc
composit
function
cell
cultur
media
uv
inactiv
gener
achiev
use
lamp
emit
nm
wavelength
uvc
rang
produc
effici
use
mercuri
vapor
lamp
nearli
correspond
nucleic
acid
absorpt
peak
nm
absorb
energi
result
pyrimidin
cyclobutan
dimer
format
dimer
form
critic
locat
overcom
repair
mechan
organ
reproduc
therebi
inactiv
amount
uv
relev
inactiv
properli
denot
fluenc
directionindepend
irradianceanalog
multipli
exposur
time
unit
fluenc
energi
per
unit
area
attempt
predict
uv
sensit
organ
correl
genom
size
singlestrand
vs
doublestrand
dna
vs
rna
detail
genom
analysi
model
predict
good
gener
agreement
experi
allow
estim
uv
sensit
newli
discov
organ
case
experiment
result
avail
howev
even
detail
mechanist
predict
kowalski
differ
factor
specif
experiment
result
reason
review
consid
experiment
measur
inactiv
rate
model
predict
includ
sever
review
articl
identifi
adventiti
agent
concern
cho
cell
process
base
known
contamin
event
known
suscept
object
studi
provid
critic
review
avail
uv
inactiv
literatur
organ
crucial
biopharmaceut
industri
provid
comprehens
list
organ
studi
along
uv
sensit
work
hope
valuabl
sourc
inform
design
uv
disinfect
equip
experi
well
provid
research
foundat
evalu
analyz
uv
inactiv
studi
uv
sensit
gener
measur
appli
wellquantifi
singlevalu
uv
fluenc
fluid
contain
viru
determin
result
degre
inactiv
viru
process
repeat
sequenc
fluenc
valu
result
inactiv
plot
determin
shape
inactiv
curv
kinet
minim
impact
error
one
data
point
firstord
kinet
valu
fluenc
requir
singl
log
reduct
infect
readili
determin
slope
result
plot
qualiti
data
uv
inactiv
studi
check
simpl
plot
surviv
vs
uv
fluenc
organ
uv
inactiv
well
model
firstord
equat
number
infect
viru
particl
n
exponenti
function
appli
fluenc
f
multipli
origin
amount
infect
viru
n
plot
log
number
viabl
viru
vs
fluenc
data
form
straight
line
mani
virus
simpl
check
data
qualiti
done
examin
log
plot
data
data
deviat
typic
straight
line
may
indic
experi
flaw
fig
plot
data
two
differ
investig
uv
inactiv
felin
caliciviru
fcv
seen
result
park
et
al
show
firstord
kinet
log
inactiv
result
nuanualsuwan
et
al
show
tail
maximum
inactiv
log
work
nuanualsuwan
et
al
also
show
tail
phage
log
contrast
firstord
kinet
report
battigelli
et
al
even
beyond
log
inactiv
fig
although
organ
may
exhibit
firstord
kinet
uv
inactiv
firstord
kinet
common
respons
uv
irradi
data
set
compar
literatur
result
determin
expect
inactiv
kinet
viru
virus
famili
genu
deviat
expect
kinet
may
result
number
factor
discuss
examin
outlier
literatur
review
appar
author
precis
appli
singl
fluenc
valu
instead
appli
fluenc
distribut
includ
higher
lower
valu
quot
appli
wellquantifi
monovalu
fluenc
requir
care
design
irradi
apparatu
care
fluid
character
usual
care
mix
fluenc
detector
difficult
design
construct
calibr
ideal
fluenc
sensor
would
spheric
detector
equal
sensit
radiat
arriv
direct
steradian
investig
use
small
spheric
contain
chemic
actinometri
solut
small
coat
plastic
sphere
chang
fluoresc
color
uv
fluenc
approach
permit
realtim
measur
creat
fluenc
detector
electron
readout
nearli
imposs
solut
dilemma
use
irradi
geometri
irradi
sensor
suffic
sinc
avail
vendor
eg
intern
light
technolog
solar
light
along
calibr
traceabl
us
nation
institut
standard
nist
nation
laboratori
uv
irradi
must
accur
known
fluenc
calcul
guidelin
appli
uv
fluenc
bolton
linden
recommend
use
collim
beam
apparatu
devic
actual
collim
uv
radiat
field
effect
use
apertur
ensur
uv
reach
fluid
singl
direct
directli
fluid
import
two
reason
ensur
incid
irradi
measur
accur
ensur
attenu
radiat
field
fluid
sampl
calcul
accur
uv
flux
reach
fluid
sampl
varieti
direct
uv
sensor
quantifi
fluenc
rate
sensor
design
respons
drop
angl
incid
deviat
normal
welldesign
irradi
sensor
respons
vari
cosin
angl
incid
howev
virus
respond
differ
offaxi
radiat
onaxi
fluenc
rate
irradi
appropri
measur
quantiti
solut
uv
reach
sampl
singl
angl
orient
uv
sensor
normal
radiat
condit
irradi
fluenc
rate
ident
irradi
read
correct
attenu
radiat
field
fluid
sampl
readili
calcul
sinc
geometri
simpl
also
import
correct
attenu
uv
fluenc
fluid
sampl
organ
viru
suspend
radiat
field
fluid
sampl
must
calcul
fluid
depth
absorb
done
use
measur
irradi
fluid
surfac
measur
optic
absorb
fluid
relev
wavelength
usual
nm
intens
nonscatt
fluid
may
calcul
beerlambertbougu
law
assum
fluid
well
mix
irradi
time
long
compar
mix
time
express
volumeaverag
intens
readili
found
integr
equat
govern
averag
fluenc
wellmix
semitranspar
media
publish
morowitz
express
averag
fluenc
rate
f
avg
f
incid
fluenc
rate
e
absorpt
coeffici
base
e
wavelength
interest
l
fluid
depth
direct
radiat
field
express
function
common
absorpt
coeffici
equat
becom
number
correct
factor
highlight
bolton
linden
guidelin
absorpt
factor
signific
mani
configur
use
inactiv
studi
sinc
suspens
organ
virus
often
strong
absorb
uv
rang
clump
result
appar
deviat
true
inactiv
kinet
organ
viral
particl
fulli
dispers
present
clump
may
result
inactiv
plot
plateau
result
shield
central
viru
bacterium
surround
allow
central
viru
bacterium
surviv
exampl
viru
particl
fulli
shield
effect
tail
log
reduct
fulli
dispers
viru
demonstr
intrins
kinet
higher
inactiv
level
effect
recogn
address
fur
da
studi
uv
inactiv
kinet
mycoplasma
use
sonic
filtrat
ensur
singlecel
suspens
fur
note
suspens
contain
singl
cell
confirm
demonstr
colonyform
unit
cfu
inactiv
exponenti
ultraviolet
irradi
fluid
optic
poor
mix
also
lead
tail
doserespons
curv
fluid
sampl
adequ
mix
compon
sampl
receiv
integr
uv
exposur
fluenc
lessirradi
fluid
domin
result
lead
plateau
inactiv
extrem
exampl
one
part
fluid
receiv
zero
fluenc
inactiv
exceed
log
even
exposur
time
increas
similar
though
less
extrem
behavior
result
poor
dose
distribut
surviv
domin
lowdos
fluid
region
reason
prefer
conduct
inactiv
studi
rel
clear
solut
minim
intens
gradient
lessen
import
mix
likewis
irradi
devic
collim
beam
also
set
minim
uv
intens
gradient
across
surfac
fluid
sampl
deviat
uniform
denot
petri
factor
method
publish
bolton
linden
method
provid
quantifi
magnitud
effect
well
recommend
accept
rang
import
util
relev
assay
determin
whether
infecti
viru
remain
irradi
assay
tissu
cultur
infecti
dose
tcid
plaqu
assay
correctli
assess
infect
morpholog
chang
detector
cell
due
viral
infect
basi
tcid
assay
respons
plaqu
format
pcr
method
signific
drawback
measur
degre
disinfect
may
unabl
distinguish
viabl
inactiv
organ
detect
specif
sequenc
indic
presenc
intact
infecti
virion
even
presenc
viral
sequenc
host
cell
indic
infecti
viru
sinc
viru
might
enter
host
cell
still
abl
replic
care
must
taken
ensur
assay
quantifi
infecti
viru
randazzo
et
al
ju
et
al
investig
abil
pcrbase
techniqu
distinguish
viabl
inactiv
noroviru
e
coli
respect
paper
author
examin
abil
rtqpcr
reversetranscriptas
quantit
pcr
augment
photoactivat
dye
method
propidium
monoazid
ethidium
monoazid
discrimin
viabl
inactiv
organ
rtpcr
amplifi
rna
thought
therefor
detect
viabl
organ
express
rna
rna
viru
dye
furthermor
intend
prevent
amplif
nucleic
acid
organ
compromis
capsid
sinc
dye
penetr
nucleu
prevent
amplif
randazzo
found
even
best
combin
dye
abl
suppress
log
thermal
inactiv
noroviru
ju
et
al
found
similar
issu
discrep
cultur
qpcr
result
e
coli
inactiv
desicc
disinfect
applic
log
greater
inactiv
expect
method
correct
inher
overestim
viabl
viru
qpcr
method
furthermor
uv
disinfect
leav
capsid
virtual
intact
limit
perform
dye
techniqu
author
present
review
recommend
pcr
method
assess
uv
disinfect
uv
inactiv
kinet
often
first
order
commonli
describ
dose
requir
reduc
count
one
log
defin
larger
valu
indic
organ
resist
uv
inactiv
consid
pitfal
methodolog
overal
consist
within
multipl
research
lab
averag
valu
base
experiment
result
propos
tabl
base
thorough
review
literatur
valu
fig
fig
appendix
tabl
unless
address
text
report
valu
tabl
simpli
arithmet
averag
avail
literatur
list
appendix
gener
experiment
determin
uv
sensit
valu
consist
across
multipl
laboratori
fig
tabl
give
confid
report
valu
inconsist
experiment
data
review
discuss
fig
review
focus
bacteria
concern
adventiti
agent
biopharmaceut
product
extens
review
avail
bacteria
organ
includ
hijnen
two
organ
particular
interest
adventiti
agent
mycoplasma
leptospira
mycoplasma
acholeplasma
contamin
rel
common
sinc
bacteria
lack
cell
wall
unaffect
mani
common
antibiot
approxim
diamet
make
difficult
remov
via
typic
steril
filtrat
sever
strain
mycoplasma
acholeplasma
evalu
sensit
uv
irradi
one
outlier
data
set
result
kurth
report
full
clearanc
mycoplasma
therefor
precis
uv
sensit
determin
data
set
kurth
experiment
result
show
valu
mjcm
indic
mycoplasma
acholeplasma
highli
suscept
uv
inactiv
leptospira
concern
biopharmaceut
product
sinc
minor
dimens
micron
allow
penetr
mani
filter
especi
design
bacteria
pore
size
often
micron
valu
leptospira
report
stamm
charon
fonseca
rang
mjcm
indic
high
suscept
uv
disinfect
stamm
charon
provid
minim
inform
methodolog
discuss
fluid
optic
difficult
determin
whether
leptospira
data
reliabl
author
review
could
find
quantit
data
uv
sensit
leptospira
repres
area
addit
research
escherichia
coli
studi
mani
investig
readili
inactiv
uv
strain
found
shoulder
inactiv
curv
low
uv
dose
small
impact
inactiv
increas
impact
higher
dose
reason
valu
summari
tabl
base
inactiv
data
simpli
divid
dose
inactiv
factor
conserv
higher
level
inactiv
sinc
uv
broadspectrum
inactiv
method
like
size
dose
would
achiev
inactiv
e
coli
fluenc
mjcm
author
feel
inher
conserv
individu
author
report
valu
multipl
strain
singl
averag
valu
use
intend
avoid
give
extra
emphasi
individu
author
systemat
approach
averag
valu
e
coli
mjcm
confirm
organ
highli
suscept
uv
inactiv
felin
caliciviru
studi
number
investig
find
rel
sensit
uv
inactiv
averag
mjcm
fig
outlier
case
result
nuanualsuwan
et
al
report
valu
higher
valu
report
hepat
viru
polioviru
significantli
higher
research
sever
concern
methodolog
report
nuanualsuwan
et
al
would
caus
erron
result
first
use
long
lamp
cm
close
cm
petri
dish
irradi
geometri
make
difficult
obtain
accur
flux
measur
caus
shadow
near
edg
dish
combin
geometri
lack
agit
poor
fluenc
uniform
like
data
present
display
signific
tail
high
fluenc
fig
consist
lack
uniform
addit
determin
valu
research
use
trend
line
entir
rang
fluenc
singl
log
reduct
viru
actual
occur
much
lower
uv
fluenc
present
therefor
consid
valu
report
nuanualsuwan
et
al
accur
anoth
organ
concern
porcin
circoviru
pcv
detect
commerci
rotaviru
vaccin
rotarix
gsk
enter
biopharmaceut
product
process
trypsin
use
cell
line
develop
recent
guidanc
european
medicin
agenc
recommend
use
two
complementari
viru
reduct
step
trypsin
includ
final
inactiv
step
gamma
ebeam
uv
irradi
uv
sensit
pcv
measur
lackner
et
al
remington
rang
mjcm
although
rang
larg
percentag
moder
sensit
report
investig
indic
pcv
readili
inactiv
uv
littl
consist
valu
report
bovin
viral
diarrhea
viru
bvdv
rang
valu
mjcm
fig
three
five
studi
report
valu
less
mjcm
valu
mjcm
report
daryani
et
al
remark
high
experiment
apparatu
involv
uv
lamp
place
close
cm
sampl
methodolog
indic
absorb
fluid
presenc
agit
suggest
fluid
stir
optic
absorb
consid
factor
would
lead
lack
uniform
fluenc
deliveri
caus
portion
fluid
evad
irradi
increas
appar
true
would
lower
determin
publish
inform
valu
mjcm
report
steinmann
et
al
fluid
case
platelet
concentr
would
higher
absorb
compar
typic
phosphat
buffer
minim
experiment
inform
provid
studi
indic
fluid
absorb
consid
calcul
fluenc
deliveri
would
fals
increas
appar
resist
uv
disinfect
method
would
correctli
measur
inher
uv
sensit
base
uncertainti
consensu
valu
mjcm
recommend
addit
studi
warrant
one
particularli
import
adventiti
agent
mous
minut
viru
mmv
potenti
contamin
biopharmaceut
product
known
resist
physicochem
treatment
sensit
uv
inactiv
consensu
mj
cm
fig
outlier
data
report
schleh
et
al
public
full
viral
clearanc
achiev
actual
valu
lower
calcul
valu
also
minim
inform
experi
provid
make
difficult
critic
assess
methodolog
true
valu
cach
valley
viru
determin
public
mous
polyoma
viru
mpyv
four
public
report
similar
result
consensu
valu
mjcm
heberman
ting
report
valu
roughli
three
time
higher
fig
heberman
ting
report
surfac
energi
fluenc
consid
absorb
fluid
could
lead
erron
valu
like
high
result
simian
vacuol
viru
type
repres
interest
case
sinc
numer
uv
irradi
studi
wide
rang
valu
report
fig
outlier
highand
lowsensit
side
averag
without
two
valu
mjcm
compar
low
mj
cm
wang
et
al
high
valu
mjcm
bourr
et
al
author
present
review
measur
approxim
mjcm
consist
consensu
literatur
valu
may
repres
worst
case
design
organ
uv
inactiv
highest
resist
uv
inactiv
organ
consid
contrast
previou
assumpt
author
uv
irradi
singlestrand
genom
sensit
uv
doublestrand
genom
evid
fig
uv
resist
simpli
correl
overal
natur
genom
resist
virus
rang
genom
type
ssdna
mjcm
mous
polyoma
viru
ssdna
mjcm
adenoviru
dsdna
mjcm
therefor
uv
sensit
simpli
correl
nucleic
acid
conform
success
model
proprietari
model
kowalski
take
account
detail
includ
locat
frequenc
pyrimidin
although
uv
disinfect
broadli
appli
industri
drink
water
high
uv
transpar
municip
wastewat
lower
uv
transpar
wide
accept
biopharmaceut
applic
commerci
avail
uv
system
design
biopharmaceut
sartoriu
uvivatec
larg
cell
line
develop
small
fullscal
batch
product
compar
drink
water
wastewat
uv
treatment
cell
cultur
media
complic
opac
fluid
well
requisit
minim
uv
dose
deliveri
avoid
damag
essenti
compon
media
therefor
biopharmaceut
applic
would
necessit
customdesign
uv
equip
similarli
design
system
fluid
high
optic
absorb
stringent
regul
appl
cider
fdaapprov
cidersur
headwat
food
rochest
ny
sugar
solut
aquafin
ls
hx
aquafin
corpor
valencia
ca
biopharmaceut
industri
progress
dispos
product
equip
uv
technolog
could
well
dispos
provid
steril
dispos
disinfect
system
author
present
review
use
famili
prototyp
reactor
wet
part
consist
dispos
teflon
design
scale
intern
volum
ml
correspond
increas
flow
design
could
readili
scale
achiev
rang
dispos
uv
reactor
suitabl
perfus
parallel
batch
product
knowledg
uv
sensit
adventiti
agent
crucial
effici
size
oper
uv
reactor
biopharmaceut
applic
high
log
reduct
readili
achiev
uv
disinfect
water
treatment
phage
commonli
use
verifi
uv
fluenc
phage
stock
avail
titr
pfuml
inocul
test
fluid
treat
uv
equip
typic
titr
pfu
ml
may
fulli
inactiv
commonli
test
design
countabl
titr
treatment
fluenc
calcul
log
inactiv
known
uv
sensit
phage
particleassoci
one
primari
caus
deviat
firstord
kinet
phage
viru
fluid
treat
cell
cultur
medium
contain
particl
could
shelter
virus
firstord
kinet
expect
log
inactiv
present
review
found
experiment
determin
nm
sensit
valu
mani
adventiti
agent
biopharmaceut
industri
report
fairli
consist
differ
research
group
base
experiment
data
avail
literatur
outlier
explan
inconsist
result
highlight
review
avail
data
averag
sensit
valu
establish
use
design
size
uv
disinfect
system
inactiv
specif
agent
addit
common
pitfal
experiment
design
uv
treatment
identifi
neglect
consid
fluid
absorb
proper
light
distribut
sampl
surfac
consid
fluenc
intens
surfac
sampl
rather
within
liquid
adventiti
agent
identifi
concern
cho
cell
process
includ
review
reliabl
uv
sensit
data
follow
agent
readili
avail
merit
studi
bluetongu
viru
bovin
coronaviru
bovin
polyoma
viru
bovin
respiratori
syncyti
viru
epizoot
hemorrhag
diseas
viru
monkey
pox
viru
mycobacteria
vesiviru
